Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUTCHMED

23.200
-0.300-1.28%
Volume:5.50M
Turnover:127.78M
Market Cap:20.23B
PE:67.82
High:24.050
Open:23.700
Low:22.950
Close:23.500
Loading ...

HUTCHMED (China) FY Net Income USD 37.7 Million

THOMSON REUTERS
·
19 Mar

Hutchmed, Innovent Combo Therapy Hits PFS Target in Renal Cancer Study

MT Newswires Live
·
19 Mar

Hutchmed (China) Says Frusica-2 Phase II/III Study Met Primary Endpoint

Reuters
·
19 Mar

HUTCHMED (China) FY Revenue USD 203 Million VS. Ibes Estimate USD 673.5 Million

THOMSON REUTERS
·
13 Mar

Hutchmed (China) Completes Enrolment for Bile Duct Cancer Drug Trial

MT Newswires Live
·
07 Mar

Hutchmed Completes Enrollment for Phase 2 Primary Bile Duct Cancer Study

MT Newswires Live
·
06 Mar

HUTCHMED Announces That It Has Completed Enrollment of a Phase Ii Registration Study of Fanregratinib (Hmpl-453) for Intrahepatic Cholangiocarcinoma in China

THOMSON REUTERS
·
06 Mar

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

GlobeNewswire
·
05 Mar

Hutchmed Agrees to Dispose 35% of Subsidiary to GP Health Service Capital

MT Newswires Live
·
04 Mar

Maxland Malaysia 2nd-Quarter 2024 Earnings Summary Table

Dow Jones
·
28 Feb

Jiankun International Malaysia 2nd-Quarter 2024 Earnings Summary Table

Dow Jones
·
26 Feb

Lion Posim Malaysia 4th-Quarter 2024 Earnings Summary Table

Dow Jones
·
21 Feb

HUTCHMED to Announce 2024 Final Results

GlobeNewswire
·
19 Feb

BofA Securities Adjusts Price Target on HUTCHMED (China) to $27 From $26, Maintains Buy Rating

MT Newswires Live
·
11 Feb

Hutchmed Delays Circular Dispatch for Shanghai Hutchinson Pharma Stake Disposal

MT Newswires Live
·
29 Jan

BRIEF-Hutchmed (China) Says Disposal Of Stake In Shanghai Hutchison Pharmaceuticals

Reuters
·
28 Jan

HUTCHMED (China) - Expects Circular With Details on Terms of Disposal Will Be Dispatched on or Before Feb 28

THOMSON REUTERS
·
28 Jan

HUTCHMED (China) Ltd - Disposal of 45% Equity Interest in Shanghai Hutchison Pharmaceuticals Limited

THOMSON REUTERS
·
28 Jan

Hutchmed Gets China Approval for Non-Small Cell Lung Cancer Mutation

MT Newswires Live
·
14 Jan

Hutchmed Says Orpathys Receives Full Approval in China

MT Newswires Live
·
14 Jan